nodes	percent_of_prediction	percent_of_DWPC	metapath
Reserpine—ABCB1—Mitomycin—urinary bladder cancer	0.12	0.148	CbGbCtD
Reserpine—ABCB11—Doxorubicin—urinary bladder cancer	0.0982	0.121	CbGbCtD
Reserpine—SLC22A2—Cisplatin—urinary bladder cancer	0.0944	0.116	CbGbCtD
Reserpine—ABCC2—Carboplatin—urinary bladder cancer	0.0902	0.111	CbGbCtD
Reserpine—ABCC2—Cisplatin—urinary bladder cancer	0.0771	0.0948	CbGbCtD
Reserpine—ABCC2—Etoposide—urinary bladder cancer	0.0757	0.0932	CbGbCtD
Reserpine—ABCC2—Doxorubicin—urinary bladder cancer	0.0516	0.0635	CbGbCtD
Reserpine—ABCC2—Methotrexate—urinary bladder cancer	0.05	0.0615	CbGbCtD
Reserpine—CYP3A5—Etoposide—urinary bladder cancer	0.0379	0.0467	CbGbCtD
Reserpine—ABCB1—Gemcitabine—urinary bladder cancer	0.0346	0.0425	CbGbCtD
Reserpine—ABCB1—Cisplatin—urinary bladder cancer	0.0251	0.0309	CbGbCtD
Reserpine—ABCB1—Etoposide—urinary bladder cancer	0.0247	0.0304	CbGbCtD
Reserpine—ABCB1—Doxorubicin—urinary bladder cancer	0.0168	0.0207	CbGbCtD
Reserpine—ABCB1—Methotrexate—urinary bladder cancer	0.0163	0.0201	CbGbCtD
Reserpine—SLC18A1—vagina—urinary bladder cancer	0.00385	0.148	CbGeAlD
Reserpine—Parkinsonism—Fluorouracil—urinary bladder cancer	0.00286	0.0332	CcSEcCtD
Reserpine—Dysuria—Valrubicin—urinary bladder cancer	0.00266	0.0309	CcSEcCtD
Reserpine—SLC18A2—prostate gland—urinary bladder cancer	0.00249	0.0956	CbGeAlD
Reserpine—SLC18A1—lymph node—urinary bladder cancer	0.00249	0.0956	CbGeAlD
Reserpine—SLC22A1—Amine compound SLC transporters—SLC14A2—urinary bladder cancer	0.00203	0.0271	CbGpPWpGaD
Reserpine—CYP3A5—Tamoxifen metabolism—UGT2B7—urinary bladder cancer	0.00192	0.0256	CbGpPWpGaD
Reserpine—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.00188	0.0251	CbGpPWpGaD
Reserpine—SLC22A2—renal system—urinary bladder cancer	0.00179	0.0688	CbGeAlD
Reserpine—Drowsiness—Mitomycin—urinary bladder cancer	0.00175	0.0203	CcSEcCtD
Reserpine—SLC18A1—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.00175	0.0233	CbGpPWpGaD
Reserpine—ABCC2—prostate gland—urinary bladder cancer	0.00167	0.0639	CbGeAlD
Reserpine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—urinary bladder cancer	0.00157	0.0209	CbGpPWpGaD
Reserpine—CYP3A5—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.00155	0.0207	CbGpPWpGaD
Reserpine—SLC18A2—female reproductive system—urinary bladder cancer	0.00136	0.0522	CbGeAlD
Reserpine—Pain—Carboplatin—urinary bladder cancer	0.00128	0.0149	CcSEcCtD
Reserpine—Deafness—Thiotepa—urinary bladder cancer	0.00128	0.0148	CcSEcCtD
Reserpine—SLC22A1—renal system—urinary bladder cancer	0.00127	0.0486	CbGeAlD
Reserpine—SLC18A2—vagina—urinary bladder cancer	0.00123	0.0472	CbGeAlD
Reserpine—Syncope—Mitomycin—urinary bladder cancer	0.00123	0.0142	CcSEcCtD
Reserpine—Loss of consciousness—Mitomycin—urinary bladder cancer	0.0012	0.0139	CcSEcCtD
Reserpine—Pruritus—Valrubicin—urinary bladder cancer	0.00115	0.0133	CcSEcCtD
Reserpine—ABCC2—renal system—urinary bladder cancer	0.00114	0.0436	CbGeAlD
Reserpine—CYP3A5—prostate gland—urinary bladder cancer	0.00113	0.0433	CbGeAlD
Reserpine—Oedema—Mitomycin—urinary bladder cancer	0.00112	0.0129	CcSEcCtD
Reserpine—Diarrhoea—Valrubicin—urinary bladder cancer	0.00111	0.0129	CcSEcCtD
Reserpine—Shock—Mitomycin—urinary bladder cancer	0.0011	0.0127	CcSEcCtD
Reserpine—Deafness—Gemcitabine—urinary bladder cancer	0.00107	0.0125	CcSEcCtD
Reserpine—Dizziness—Valrubicin—urinary bladder cancer	0.00107	0.0124	CcSEcCtD
Reserpine—Anorexia—Mitomycin—urinary bladder cancer	0.00106	0.0123	CcSEcCtD
Reserpine—Vomiting—Valrubicin—urinary bladder cancer	0.00103	0.0119	CcSEcCtD
Reserpine—Rash—Valrubicin—urinary bladder cancer	0.00102	0.0118	CcSEcCtD
Reserpine—Dermatitis—Valrubicin—urinary bladder cancer	0.00102	0.0118	CcSEcCtD
Reserpine—Headache—Valrubicin—urinary bladder cancer	0.00102	0.0118	CcSEcCtD
Reserpine—Deafness—Cisplatin—urinary bladder cancer	0.001	0.0116	CcSEcCtD
Reserpine—Dyspnoea—Mitomycin—urinary bladder cancer	0.000995	0.0115	CcSEcCtD
Reserpine—Somnolence—Mitomycin—urinary bladder cancer	0.000992	0.0115	CcSEcCtD
Reserpine—Nasal congestion—Cisplatin—urinary bladder cancer	0.000983	0.0114	CcSEcCtD
Reserpine—Decreased appetite—Mitomycin—urinary bladder cancer	0.00097	0.0113	CcSEcCtD
Reserpine—ABCC2—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000966	0.0129	CbGpPWpGaD
Reserpine—Nausea—Valrubicin—urinary bladder cancer	0.000962	0.0112	CcSEcCtD
Reserpine—Pain—Mitomycin—urinary bladder cancer	0.000955	0.0111	CcSEcCtD
Reserpine—Dysuria—Thiotepa—urinary bladder cancer	0.000923	0.0107	CcSEcCtD
Reserpine—SLC22A1—vagina—urinary bladder cancer	0.000918	0.0352	CbGeAlD
Reserpine—ABCC2—female reproductive system—urinary bladder cancer	0.00091	0.0349	CbGeAlD
Reserpine—Weight increased—Thiotepa—urinary bladder cancer	0.000898	0.0104	CcSEcCtD
Reserpine—SLC18A1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000887	0.0118	CbGpPWpGaD
Reserpine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.000886	0.0118	CbGpPWpGaD
Reserpine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—urinary bladder cancer	0.000851	0.0114	CbGpPWpGaD
Reserpine—Epistaxis—Thiotepa—urinary bladder cancer	0.00083	0.00963	CcSEcCtD
Reserpine—SLC18A2—lymph node—urinary bladder cancer	0.000797	0.0305	CbGeAlD
Reserpine—Angina pectoris—Fluorouracil—urinary bladder cancer	0.000795	0.00922	CcSEcCtD
Reserpine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—urinary bladder cancer	0.000793	0.0106	CbGpPWpGaD
Reserpine—CYP3A5—renal system—urinary bladder cancer	0.000769	0.0295	CbGeAlD
Reserpine—Diarrhoea—Mitomycin—urinary bladder cancer	0.000764	0.00886	CcSEcCtD
Reserpine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.000745	0.00994	CbGpPWpGaD
Reserpine—Dizziness—Mitomycin—urinary bladder cancer	0.000738	0.00856	CcSEcCtD
Reserpine—CYP3A5—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000735	0.00981	CbGpPWpGaD
Reserpine—SLC18A2—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000713	0.00951	CbGpPWpGaD
Reserpine—Vomiting—Mitomycin—urinary bladder cancer	0.00071	0.00823	CcSEcCtD
Reserpine—Arrhythmia—Thiotepa—urinary bladder cancer	0.000706	0.00818	CcSEcCtD
Reserpine—Rash—Mitomycin—urinary bladder cancer	0.000704	0.00816	CcSEcCtD
Reserpine—Dermatitis—Mitomycin—urinary bladder cancer	0.000703	0.00815	CcSEcCtD
Reserpine—Headache—Mitomycin—urinary bladder cancer	0.000699	0.00811	CcSEcCtD
Reserpine—Epistaxis—Fluorouracil—urinary bladder cancer	0.000687	0.00796	CcSEcCtD
Reserpine—Tension—Thiotepa—urinary bladder cancer	0.000675	0.00783	CcSEcCtD
Reserpine—Nervousness—Thiotepa—urinary bladder cancer	0.000668	0.00775	CcSEcCtD
Reserpine—Nausea—Mitomycin—urinary bladder cancer	0.000663	0.00769	CcSEcCtD
Reserpine—ABCC2—NRF2 pathway—UGT2B7—urinary bladder cancer	0.000652	0.0087	CbGpPWpGaD
Reserpine—SLC18A1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000642	0.00856	CbGpPWpGaD
Reserpine—Bradycardia—Cisplatin—urinary bladder cancer	0.000631	0.00731	CcSEcCtD
Reserpine—Gynaecomastia—Methotrexate—urinary bladder cancer	0.000606	0.00702	CcSEcCtD
Reserpine—CYP3A5—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000604	0.00806	CbGpPWpGaD
Reserpine—CYP3A5—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000602	0.00803	CbGpPWpGaD
Reserpine—ABCB1—prostate gland—urinary bladder cancer	0.0006	0.023	CbGeAlD
Reserpine—Arrhythmia—Gemcitabine—urinary bladder cancer	0.000594	0.00689	CcSEcCtD
Reserpine—Arrhythmia—Fluorouracil—urinary bladder cancer	0.000584	0.00677	CcSEcCtD
Reserpine—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000584	0.00779	CbGpPWpGaD
Reserpine—Anxiety—Thiotepa—urinary bladder cancer	0.000584	0.00677	CcSEcCtD
Reserpine—CYP3A5—vagina—urinary bladder cancer	0.000557	0.0214	CbGeAlD
Reserpine—Arrhythmia—Cisplatin—urinary bladder cancer	0.000553	0.00642	CcSEcCtD
Reserpine—Anorexia—Thiotepa—urinary bladder cancer	0.000535	0.0062	CcSEcCtD
Reserpine—ABCC2—lymph node—urinary bladder cancer	0.000532	0.0204	CbGeAlD
Reserpine—SLC18A1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000523	0.00698	CbGpPWpGaD
Reserpine—Vascular purpura—Epirubicin—urinary bladder cancer	0.000514	0.00596	CcSEcCtD
Reserpine—ABCB1—seminal vesicle—urinary bladder cancer	0.000507	0.0194	CbGeAlD
Reserpine—Somnolence—Thiotepa—urinary bladder cancer	0.000499	0.00579	CcSEcCtD
Reserpine—Decreased appetite—Thiotepa—urinary bladder cancer	0.000488	0.00566	CcSEcCtD
Reserpine—Pain—Thiotepa—urinary bladder cancer	0.00048	0.00557	CcSEcCtD
Reserpine—Purpura—Epirubicin—urinary bladder cancer	0.000477	0.00553	CcSEcCtD
Reserpine—Vascular purpura—Doxorubicin—urinary bladder cancer	0.000476	0.00552	CcSEcCtD
Reserpine—Oedema—Gemcitabine—urinary bladder cancer	0.000472	0.00548	CcSEcCtD
Reserpine—Oedema—Fluorouracil—urinary bladder cancer	0.000464	0.00538	CcSEcCtD
Reserpine—Anxiety—Cisplatin—urinary bladder cancer	0.000458	0.00531	CcSEcCtD
Reserpine—ABCB1—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000454	0.00606	CbGpPWpGaD
Reserpine—Anorexia—Gemcitabine—urinary bladder cancer	0.00045	0.00522	CcSEcCtD
Reserpine—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000444	0.00592	CbGpPWpGaD
Reserpine—Anorexia—Fluorouracil—urinary bladder cancer	0.000443	0.00513	CcSEcCtD
Reserpine—Purpura—Doxorubicin—urinary bladder cancer	0.000441	0.00512	CcSEcCtD
Reserpine—ABCB1—epithelium—urinary bladder cancer	0.000441	0.0169	CbGeAlD
Reserpine—Oedema—Cisplatin—urinary bladder cancer	0.00044	0.0051	CcSEcCtD
Reserpine—Loss of consciousness—Etoposide—urinary bladder cancer	0.000434	0.00504	CcSEcCtD
Reserpine—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000421	0.00488	CcSEcCtD
Reserpine—Somnolence—Gemcitabine—urinary bladder cancer	0.00042	0.00487	CcSEcCtD
Reserpine—Anorexia—Cisplatin—urinary bladder cancer	0.00042	0.00486	CcSEcCtD
Reserpine—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000414	0.0048	CcSEcCtD
Reserpine—Somnolence—Fluorouracil—urinary bladder cancer	0.000413	0.00479	CcSEcCtD
Reserpine—CYP3A5—Biological oxidations—GSTZ1—urinary bladder cancer	0.000411	0.00548	CbGpPWpGaD
Reserpine—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00041	0.00476	CcSEcCtD
Reserpine—ABCB1—renal system—urinary bladder cancer	0.000409	0.0157	CbGeAlD
Reserpine—CYP3A5—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000405	0.00541	CbGpPWpGaD
Reserpine—Pain—Gemcitabine—urinary bladder cancer	0.000404	0.00468	CcSEcCtD
Reserpine—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000404	0.00468	CcSEcCtD
Reserpine—ABCB1—urethra—urinary bladder cancer	0.000401	0.0154	CbGeAlD
Reserpine—Dysuria—Methotrexate—urinary bladder cancer	0.000397	0.00461	CcSEcCtD
Reserpine—Pruritus—Thiotepa—urinary bladder cancer	0.000397	0.00461	CcSEcCtD
Reserpine—Pain—Fluorouracil—urinary bladder cancer	0.000397	0.0046	CcSEcCtD
Reserpine—Dyspnoea—Cisplatin—urinary bladder cancer	0.000392	0.00455	CcSEcCtD
Reserpine—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.000391	0.00454	CcSEcCtD
Reserpine—CYP3A5—Biological oxidations—GSTO2—urinary bladder cancer	0.00039	0.0052	CbGpPWpGaD
Reserpine—CYP3A5—Biological oxidations—NAT1—urinary bladder cancer	0.00039	0.0052	CbGpPWpGaD
Reserpine—Angina pectoris—Epirubicin—urinary bladder cancer	0.000387	0.00449	CcSEcCtD
Reserpine—SLC22A2—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000387	0.00516	CbGpPWpGaD
Reserpine—Anorexia—Etoposide—urinary bladder cancer	0.000384	0.00446	CcSEcCtD
Reserpine—CYP3A5—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000384	0.00513	CbGpPWpGaD
Reserpine—Diarrhoea—Thiotepa—urinary bladder cancer	0.000384	0.00445	CcSEcCtD
Reserpine—Decreased appetite—Cisplatin—urinary bladder cancer	0.000383	0.00444	CcSEcCtD
Reserpine—Drowsiness—Methotrexate—urinary bladder cancer	0.000379	0.00439	CcSEcCtD
Reserpine—Pain—Cisplatin—urinary bladder cancer	0.000376	0.00436	CcSEcCtD
Reserpine—Dysuria—Epirubicin—urinary bladder cancer	0.000372	0.00431	CcSEcCtD
Reserpine—Dizziness—Thiotepa—urinary bladder cancer	0.000371	0.0043	CcSEcCtD
Reserpine—SLC18A2—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000362	0.00483	CbGpPWpGaD
Reserpine—Weight increased—Epirubicin—urinary bladder cancer	0.000362	0.00419	CcSEcCtD
Reserpine—SLC22A1—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.00036	0.00481	CbGpPWpGaD
Reserpine—Dyspnoea—Etoposide—urinary bladder cancer	0.000359	0.00417	CcSEcCtD
Reserpine—Somnolence—Etoposide—urinary bladder cancer	0.000358	0.00416	CcSEcCtD
Reserpine—Angina pectoris—Doxorubicin—urinary bladder cancer	0.000358	0.00415	CcSEcCtD
Reserpine—Epistaxis—Methotrexate—urinary bladder cancer	0.000357	0.00414	CcSEcCtD
Reserpine—Vomiting—Thiotepa—urinary bladder cancer	0.000357	0.00414	CcSEcCtD
Reserpine—CYP3A5—Biological oxidations—UGT2B7—urinary bladder cancer	0.000356	0.00476	CbGpPWpGaD
Reserpine—Drowsiness—Epirubicin—urinary bladder cancer	0.000354	0.00411	CcSEcCtD
Reserpine—Rash—Thiotepa—urinary bladder cancer	0.000354	0.0041	CcSEcCtD
Reserpine—Dermatitis—Thiotepa—urinary bladder cancer	0.000354	0.0041	CcSEcCtD
Reserpine—SLC18A1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000353	0.00471	CbGpPWpGaD
Reserpine—Headache—Thiotepa—urinary bladder cancer	0.000352	0.00408	CcSEcCtD
Reserpine—CYP3A5—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000351	0.00469	CbGpPWpGaD
Reserpine—Decreased appetite—Etoposide—urinary bladder cancer	0.000351	0.00406	CcSEcCtD
Reserpine—Pain—Etoposide—urinary bladder cancer	0.000345	0.004	CcSEcCtD
Reserpine—Dysuria—Doxorubicin—urinary bladder cancer	0.000344	0.00399	CcSEcCtD
Reserpine—Weight increased—Doxorubicin—urinary bladder cancer	0.000335	0.00388	CcSEcCtD
Reserpine—Epistaxis—Epirubicin—urinary bladder cancer	0.000334	0.00388	CcSEcCtD
Reserpine—Pruritus—Gemcitabine—urinary bladder cancer	0.000334	0.00387	CcSEcCtD
Reserpine—Nausea—Thiotepa—urinary bladder cancer	0.000333	0.00387	CcSEcCtD
Reserpine—Pruritus—Fluorouracil—urinary bladder cancer	0.000328	0.00381	CcSEcCtD
Reserpine—Drowsiness—Doxorubicin—urinary bladder cancer	0.000328	0.0038	CcSEcCtD
Reserpine—ABCB1—female reproductive system—urinary bladder cancer	0.000327	0.0125	CbGeAlD
Reserpine—Bradycardia—Epirubicin—urinary bladder cancer	0.000324	0.00376	CcSEcCtD
Reserpine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000323	0.00375	CcSEcCtD
Reserpine—CYP3A5—Biological oxidations—CYP4B1—urinary bladder cancer	0.000321	0.00428	CbGpPWpGaD
Reserpine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000318	0.00368	CcSEcCtD
Reserpine—CYP3A5—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000316	0.00422	CbGpPWpGaD
Reserpine—Epistaxis—Doxorubicin—urinary bladder cancer	0.000309	0.00359	CcSEcCtD
Reserpine—Dizziness—Fluorouracil—urinary bladder cancer	0.000307	0.00356	CcSEcCtD
Reserpine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000301	0.00349	CcSEcCtD
Reserpine—Vomiting—Gemcitabine—urinary bladder cancer	0.0003	0.00348	CcSEcCtD
Reserpine—Bradycardia—Doxorubicin—urinary bladder cancer	0.0003	0.00347	CcSEcCtD
Reserpine—Rash—Gemcitabine—urinary bladder cancer	0.000298	0.00345	CcSEcCtD
Reserpine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000297	0.00345	CcSEcCtD
Reserpine—ABCB1—vagina—urinary bladder cancer	0.000296	0.0113	CbGeAlD
Reserpine—Headache—Gemcitabine—urinary bladder cancer	0.000296	0.00343	CcSEcCtD
Reserpine—Vomiting—Fluorouracil—urinary bladder cancer	0.000295	0.00342	CcSEcCtD
Reserpine—Rash—Fluorouracil—urinary bladder cancer	0.000293	0.00339	CcSEcCtD
Reserpine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000292	0.00339	CcSEcCtD
Reserpine—Headache—Fluorouracil—urinary bladder cancer	0.000291	0.00337	CcSEcCtD
Reserpine—Pruritus—Etoposide—urinary bladder cancer	0.000285	0.00331	CcSEcCtD
Reserpine—Arrhythmia—Epirubicin—urinary bladder cancer	0.000284	0.0033	CcSEcCtD
Reserpine—Nausea—Gemcitabine—urinary bladder cancer	0.00028	0.00325	CcSEcCtD
Reserpine—Vomiting—Cisplatin—urinary bladder cancer	0.00028	0.00325	CcSEcCtD
Reserpine—Rash—Cisplatin—urinary bladder cancer	0.000278	0.00322	CcSEcCtD
Reserpine—Dermatitis—Cisplatin—urinary bladder cancer	0.000277	0.00322	CcSEcCtD
Reserpine—Diarrhoea—Etoposide—urinary bladder cancer	0.000276	0.0032	CcSEcCtD
Reserpine—Nausea—Fluorouracil—urinary bladder cancer	0.000276	0.0032	CcSEcCtD
Reserpine—Tension—Epirubicin—urinary bladder cancer	0.000272	0.00315	CcSEcCtD
Reserpine—Nervousness—Epirubicin—urinary bladder cancer	0.000269	0.00312	CcSEcCtD
Reserpine—Dizziness—Etoposide—urinary bladder cancer	0.000267	0.00309	CcSEcCtD
Reserpine—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000263	0.00305	CcSEcCtD
Reserpine—SLC18A2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000262	0.0035	CbGpPWpGaD
Reserpine—Nausea—Cisplatin—urinary bladder cancer	0.000261	0.00303	CcSEcCtD
Reserpine—ABCB11—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.00026	0.00347	CbGpPWpGaD
Reserpine—Vomiting—Etoposide—urinary bladder cancer	0.000256	0.00297	CcSEcCtD
Reserpine—Rash—Etoposide—urinary bladder cancer	0.000254	0.00295	CcSEcCtD
Reserpine—Dermatitis—Etoposide—urinary bladder cancer	0.000254	0.00295	CcSEcCtD
Reserpine—Headache—Etoposide—urinary bladder cancer	0.000253	0.00293	CcSEcCtD
Reserpine—ABCB1—HIF-1-alpha transcription factor network—TFRC—urinary bladder cancer	0.000252	0.00336	CbGpPWpGaD
Reserpine—ABCC2—NRF2 pathway—NQO1—urinary bladder cancer	0.000252	0.00336	CbGpPWpGaD
Reserpine—Tension—Doxorubicin—urinary bladder cancer	0.000251	0.00292	CcSEcCtD
Reserpine—Nervousness—Doxorubicin—urinary bladder cancer	0.000249	0.00289	CcSEcCtD
Reserpine—Syncope—Epirubicin—urinary bladder cancer	0.000248	0.00288	CcSEcCtD
Reserpine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000243	0.00282	CcSEcCtD
Reserpine—Nausea—Etoposide—urinary bladder cancer	0.00024	0.00278	CcSEcCtD
Reserpine—Anxiety—Epirubicin—urinary bladder cancer	0.000235	0.00272	CcSEcCtD
Reserpine—Anorexia—Methotrexate—urinary bladder cancer	0.00023	0.00267	CcSEcCtD
Reserpine—Syncope—Doxorubicin—urinary bladder cancer	0.00023	0.00266	CcSEcCtD
Reserpine—ABCC2—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000228	0.00305	CbGpPWpGaD
Reserpine—Oedema—Epirubicin—urinary bladder cancer	0.000226	0.00262	CcSEcCtD
Reserpine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000225	0.00261	CcSEcCtD
Reserpine—Shock—Epirubicin—urinary bladder cancer	0.000222	0.00258	CcSEcCtD
Reserpine—Anxiety—Doxorubicin—urinary bladder cancer	0.000217	0.00252	CcSEcCtD
Reserpine—Anorexia—Epirubicin—urinary bladder cancer	0.000215	0.0025	CcSEcCtD
Reserpine—Dyspnoea—Methotrexate—urinary bladder cancer	0.000215	0.0025	CcSEcCtD
Reserpine—Somnolence—Methotrexate—urinary bladder cancer	0.000215	0.00249	CcSEcCtD
Reserpine—SLC18A2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000214	0.00285	CbGpPWpGaD
Reserpine—CYP3A5—Biological oxidations—NAT2—urinary bladder cancer	0.000213	0.00285	CbGpPWpGaD
Reserpine—CYP3A5—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000211	0.00281	CbGpPWpGaD
Reserpine—Decreased appetite—Methotrexate—urinary bladder cancer	0.00021	0.00243	CcSEcCtD
Reserpine—ABCC2—NRF2 pathway—GSTP1—urinary bladder cancer	0.00021	0.0028	CbGpPWpGaD
Reserpine—Oedema—Doxorubicin—urinary bladder cancer	0.000209	0.00243	CcSEcCtD
Reserpine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000209	0.00278	CbGpPWpGaD
Reserpine—Pain—Methotrexate—urinary bladder cancer	0.000207	0.00239	CcSEcCtD
Reserpine—Shock—Doxorubicin—urinary bladder cancer	0.000206	0.00239	CcSEcCtD
Reserpine—Dyspnoea—Epirubicin—urinary bladder cancer	0.000202	0.00234	CcSEcCtD
Reserpine—Somnolence—Epirubicin—urinary bladder cancer	0.000201	0.00233	CcSEcCtD
Reserpine—Anorexia—Doxorubicin—urinary bladder cancer	0.000199	0.00231	CcSEcCtD
Reserpine—SLC22A2—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000196	0.00262	CbGpPWpGaD
Reserpine—Decreased appetite—Epirubicin—urinary bladder cancer	0.000196	0.00228	CcSEcCtD
Reserpine—Pain—Epirubicin—urinary bladder cancer	0.000193	0.00224	CcSEcCtD
Reserpine—ABCC2—NRF2 pathway—GSTM1—urinary bladder cancer	0.000193	0.00257	CbGpPWpGaD
Reserpine—ABCB1—lymph node—urinary bladder cancer	0.000191	0.00734	CbGeAlD
Reserpine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000186	0.00216	CcSEcCtD
Reserpine—Somnolence—Doxorubicin—urinary bladder cancer	0.000186	0.00216	CcSEcCtD
Reserpine—SLC22A1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000183	0.00244	CbGpPWpGaD
Reserpine—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000182	0.00211	CcSEcCtD
Reserpine—Pain—Doxorubicin—urinary bladder cancer	0.000179	0.00207	CcSEcCtD
Reserpine—Pruritus—Methotrexate—urinary bladder cancer	0.000171	0.00198	CcSEcCtD
Reserpine—CYP3A5—Biological oxidations—HPGDS—urinary bladder cancer	0.000171	0.00228	CbGpPWpGaD
Reserpine—CYP3A5—Biological oxidations—GSTT1—urinary bladder cancer	0.000166	0.00221	CbGpPWpGaD
Reserpine—SLC18A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000165	0.00221	CbGpPWpGaD
Reserpine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000165	0.00192	CcSEcCtD
Reserpine—ABCC2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000165	0.0022	CbGpPWpGaD
Reserpine—Pruritus—Epirubicin—urinary bladder cancer	0.00016	0.00185	CcSEcCtD
Reserpine—Dizziness—Methotrexate—urinary bladder cancer	0.00016	0.00185	CcSEcCtD
Reserpine—ABCB1—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.000155	0.00207	CbGpPWpGaD
Reserpine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000155	0.00179	CcSEcCtD
Reserpine—Vomiting—Methotrexate—urinary bladder cancer	0.000154	0.00178	CcSEcCtD
Reserpine—Rash—Methotrexate—urinary bladder cancer	0.000152	0.00177	CcSEcCtD
Reserpine—Dermatitis—Methotrexate—urinary bladder cancer	0.000152	0.00176	CcSEcCtD
Reserpine—Headache—Methotrexate—urinary bladder cancer	0.000151	0.00175	CcSEcCtD
Reserpine—ABCB1—HIF-1-alpha transcription factor network—TERT—urinary bladder cancer	0.000151	0.00201	CbGpPWpGaD
Reserpine—Dizziness—Epirubicin—urinary bladder cancer	0.000149	0.00173	CcSEcCtD
Reserpine—ABCB11—Metabolism—GSTZ1—urinary bladder cancer	0.000148	0.00198	CbGpPWpGaD
Reserpine—Pruritus—Doxorubicin—urinary bladder cancer	0.000148	0.00172	CcSEcCtD
Reserpine—SLC18A2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000144	0.00192	CbGpPWpGaD
Reserpine—Vomiting—Epirubicin—urinary bladder cancer	0.000144	0.00167	CcSEcCtD
Reserpine—Nausea—Methotrexate—urinary bladder cancer	0.000143	0.00166	CcSEcCtD
Reserpine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000143	0.00166	CcSEcCtD
Reserpine—Rash—Epirubicin—urinary bladder cancer	0.000143	0.00165	CcSEcCtD
Reserpine—Dermatitis—Epirubicin—urinary bladder cancer	0.000142	0.00165	CcSEcCtD
Reserpine—SLC22A2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000142	0.0019	CbGpPWpGaD
Reserpine—Headache—Epirubicin—urinary bladder cancer	0.000142	0.00164	CcSEcCtD
Reserpine—ABCB11—Metabolism—GSTO2—urinary bladder cancer	0.000141	0.00188	CbGpPWpGaD
Reserpine—ABCB11—Metabolism—NAT1—urinary bladder cancer	0.000141	0.00188	CbGpPWpGaD
Reserpine—ABCB11—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000138	0.00185	CbGpPWpGaD
Reserpine—Dizziness—Doxorubicin—urinary bladder cancer	0.000138	0.0016	CcSEcCtD
Reserpine—ABCC2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000135	0.0018	CbGpPWpGaD
Reserpine—Nausea—Epirubicin—urinary bladder cancer	0.000134	0.00156	CcSEcCtD
Reserpine—Vomiting—Doxorubicin—urinary bladder cancer	0.000133	0.00154	CcSEcCtD
Reserpine—ABCB1—Allograft Rejection—FAS—urinary bladder cancer	0.000133	0.00177	CbGpPWpGaD
Reserpine—SLC22A1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000132	0.00177	CbGpPWpGaD
Reserpine—Rash—Doxorubicin—urinary bladder cancer	0.000132	0.00153	CcSEcCtD
Reserpine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000132	0.00153	CcSEcCtD
Reserpine—Headache—Doxorubicin—urinary bladder cancer	0.000131	0.00152	CcSEcCtD
Reserpine—ABCB11—Metabolism—UGT2B7—urinary bladder cancer	0.000129	0.00172	CbGpPWpGaD
Reserpine—Nausea—Doxorubicin—urinary bladder cancer	0.000124	0.00144	CcSEcCtD
Reserpine—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.000118	0.00158	CbGpPWpGaD
Reserpine—ABCB1—HIF-1-alpha transcription factor network—CREBBP—urinary bladder cancer	0.000118	0.00157	CbGpPWpGaD
Reserpine—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.000118	0.00157	CbGpPWpGaD
Reserpine—ABCB11—Metabolism—CYP4B1—urinary bladder cancer	0.000116	0.00155	CbGpPWpGaD
Reserpine—SLC22A2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000116	0.00155	CbGpPWpGaD
Reserpine—CYP3A5—Biological oxidations—GSTP1—urinary bladder cancer	0.000115	0.00153	CbGpPWpGaD
Reserpine—CYP3A5—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000113	0.00151	CbGpPWpGaD
Reserpine—ABCB11—Metabolism—SLC19A1—urinary bladder cancer	0.000109	0.00146	CbGpPWpGaD
Reserpine—SLC22A1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000108	0.00144	CbGpPWpGaD
Reserpine—ABCB1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000107	0.00143	CbGpPWpGaD
Reserpine—ABCB11—Metabolism—PRSS3—urinary bladder cancer	0.000107	0.00142	CbGpPWpGaD
Reserpine—CYP3A5—Biological oxidations—GSTM1—urinary bladder cancer	0.000105	0.00141	CbGpPWpGaD
Reserpine—CYP3A5—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000104	0.00139	CbGpPWpGaD
Reserpine—SLC22A2—Metabolism—GSTZ1—urinary bladder cancer	9.71e-05	0.0013	CbGpPWpGaD
Reserpine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	9.48e-05	0.00126	CbGpPWpGaD
Reserpine—SLC22A2—Metabolism—GSTO2—urinary bladder cancer	9.2e-05	0.00123	CbGpPWpGaD
Reserpine—SLC22A2—Metabolism—NAT1—urinary bladder cancer	9.2e-05	0.00123	CbGpPWpGaD
Reserpine—ABCC2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	9.09e-05	0.00121	CbGpPWpGaD
Reserpine—SLC22A1—Metabolism—GSTZ1—urinary bladder cancer	9.05e-05	0.00121	CbGpPWpGaD
Reserpine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—urinary bladder cancer	8.88e-05	0.00118	CbGpPWpGaD
Reserpine—SLC22A1—Metabolism—GSTO2—urinary bladder cancer	8.58e-05	0.00114	CbGpPWpGaD
Reserpine—SLC22A1—Metabolism—NAT1—urinary bladder cancer	8.58e-05	0.00114	CbGpPWpGaD
Reserpine—ABCB11—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	8.55e-05	0.00114	CbGpPWpGaD
Reserpine—ABCB11—Metabolism—TYMP—urinary bladder cancer	8.52e-05	0.00114	CbGpPWpGaD
Reserpine—SLC22A2—Metabolism—UGT2B7—urinary bladder cancer	8.42e-05	0.00112	CbGpPWpGaD
Reserpine—ABCB11—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	8.19e-05	0.00109	CbGpPWpGaD
Reserpine—ABCB1—Allograft Rejection—CXCL8—urinary bladder cancer	8.11e-05	0.00108	CbGpPWpGaD
Reserpine—ABCB1—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	8.03e-05	0.00107	CbGpPWpGaD
Reserpine—SLC22A1—Metabolism—UGT2B7—urinary bladder cancer	7.85e-05	0.00105	CbGpPWpGaD
Reserpine—SLC22A2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	7.82e-05	0.00104	CbGpPWpGaD
Reserpine—ABCB1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	7.76e-05	0.00104	CbGpPWpGaD
Reserpine—ABCB1—Allograft Rejection—IL2—urinary bladder cancer	7.75e-05	0.00103	CbGpPWpGaD
Reserpine—ABCB11—Metabolism—NAT2—urinary bladder cancer	7.71e-05	0.00103	CbGpPWpGaD
Reserpine—SLC18A2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	7.64e-05	0.00102	CbGpPWpGaD
Reserpine—SLC22A2—Metabolism—CYP4B1—urinary bladder cancer	7.58e-05	0.00101	CbGpPWpGaD
Reserpine—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	7.54e-05	0.00101	CbGpPWpGaD
Reserpine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	7.4e-05	0.000988	CbGpPWpGaD
Reserpine—SLC22A1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	7.29e-05	0.000973	CbGpPWpGaD
Reserpine—SLC22A2—Metabolism—SLC19A1—urinary bladder cancer	7.16e-05	0.000955	CbGpPWpGaD
Reserpine—SLC22A1—Metabolism—CYP4B1—urinary bladder cancer	7.06e-05	0.000943	CbGpPWpGaD
Reserpine—CYP3A5—Metabolism—GSTZ1—urinary bladder cancer	7.03e-05	0.000938	CbGpPWpGaD
Reserpine—SLC22A2—Metabolism—PRSS3—urinary bladder cancer	6.97e-05	0.000931	CbGpPWpGaD
Reserpine—SLC18A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.75e-05	0.000901	CbGpPWpGaD
Reserpine—SLC22A1—Metabolism—SLC19A1—urinary bladder cancer	6.67e-05	0.00089	CbGpPWpGaD
Reserpine—CYP3A5—Metabolism—GSTO2—urinary bladder cancer	6.66e-05	0.000889	CbGpPWpGaD
Reserpine—CYP3A5—Metabolism—NAT1—urinary bladder cancer	6.66e-05	0.000889	CbGpPWpGaD
Reserpine—ABCB11—Metabolism—RRM2—urinary bladder cancer	6.65e-05	0.000888	CbGpPWpGaD
Reserpine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	6.56e-05	0.000875	CbGpPWpGaD
Reserpine—SLC22A1—Metabolism—PRSS3—urinary bladder cancer	6.5e-05	0.000867	CbGpPWpGaD
Reserpine—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	6.33e-05	0.000844	CbGpPWpGaD
Reserpine—ABCB11—Metabolism—HPGDS—urinary bladder cancer	6.16e-05	0.000822	CbGpPWpGaD
Reserpine—ABCB11—Metabolism—ENO2—urinary bladder cancer	6.16e-05	0.000822	CbGpPWpGaD
Reserpine—ABCB11—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	6.13e-05	0.000817	CbGpPWpGaD
Reserpine—CYP3A5—Metabolism—UGT2B7—urinary bladder cancer	6.09e-05	0.000813	CbGpPWpGaD
Reserpine—ABCB11—Metabolism—GSTT1—urinary bladder cancer	5.98e-05	0.000798	CbGpPWpGaD
Reserpine—ABCB11—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	5.88e-05	0.000785	CbGpPWpGaD
Reserpine—SLC18A2—Neuronal System—HRAS—urinary bladder cancer	5.85e-05	0.000781	CbGpPWpGaD
Reserpine—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	5.8e-05	0.000773	CbGpPWpGaD
Reserpine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	5.77e-05	0.00077	CbGpPWpGaD
Reserpine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	5.75e-05	0.000767	CbGpPWpGaD
Reserpine—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	5.64e-05	0.000753	CbGpPWpGaD
Reserpine—SLC22A2—Metabolism—TYMP—urinary bladder cancer	5.58e-05	0.000744	CbGpPWpGaD
Reserpine—CYP3A5—Metabolism—CYP4B1—urinary bladder cancer	5.49e-05	0.000732	CbGpPWpGaD
Reserpine—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	5.3e-05	0.000708	CbGpPWpGaD
Reserpine—SLC22A1—Metabolism—TYMP—urinary bladder cancer	5.2e-05	0.000693	CbGpPWpGaD
Reserpine—CYP3A5—Metabolism—SLC19A1—urinary bladder cancer	5.18e-05	0.000691	CbGpPWpGaD
Reserpine—CYP3A5—Metabolism—PRSS3—urinary bladder cancer	5.05e-05	0.000674	CbGpPWpGaD
Reserpine—SLC22A2—Metabolism—NAT2—urinary bladder cancer	5.04e-05	0.000673	CbGpPWpGaD
Reserpine—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	5.04e-05	0.000672	CbGpPWpGaD
Reserpine—ABCB1—Metabolism—GSTO2—urinary bladder cancer	5.03e-05	0.000671	CbGpPWpGaD
Reserpine—ABCB1—Metabolism—NAT1—urinary bladder cancer	5.03e-05	0.000671	CbGpPWpGaD
Reserpine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	4.97e-05	0.000664	CbGpPWpGaD
Reserpine—ABCB11—Metabolism—NQO1—urinary bladder cancer	4.97e-05	0.000663	CbGpPWpGaD
Reserpine—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.82e-05	0.000643	CbGpPWpGaD
Reserpine—SLC22A1—Metabolism—NAT2—urinary bladder cancer	4.7e-05	0.000627	CbGpPWpGaD
Reserpine—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	4.6e-05	0.000614	CbGpPWpGaD
Reserpine—SLC22A2—Metabolism—RRM2—urinary bladder cancer	4.35e-05	0.000581	CbGpPWpGaD
Reserpine—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	4.27e-05	0.00057	CbGpPWpGaD
Reserpine—ABCC2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.25e-05	0.000568	CbGpPWpGaD
Reserpine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	4.22e-05	0.000563	CbGpPWpGaD
Reserpine—ABCB11—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.2e-05	0.000561	CbGpPWpGaD
Reserpine—ABCB11—Metabolism—GSTP1—urinary bladder cancer	4.14e-05	0.000553	CbGpPWpGaD
Reserpine—SLC22A2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	4.14e-05	0.000553	CbGpPWpGaD
Reserpine—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	4.14e-05	0.000552	CbGpPWpGaD
Reserpine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	4.12e-05	0.00055	CbGpPWpGaD
Reserpine—SLC22A1—Metabolism—RRM2—urinary bladder cancer	4.06e-05	0.000541	CbGpPWpGaD
Reserpine—CYP3A5—Metabolism—TYMP—urinary bladder cancer	4.04e-05	0.000539	CbGpPWpGaD
Reserpine—SLC22A2—Metabolism—HPGDS—urinary bladder cancer	4.03e-05	0.000538	CbGpPWpGaD
Reserpine—SLC22A2—Metabolism—ENO2—urinary bladder cancer	4.03e-05	0.000538	CbGpPWpGaD
Reserpine—ABCB11—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.01e-05	0.000535	CbGpPWpGaD
Reserpine—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	3.91e-05	0.000522	CbGpPWpGaD
Reserpine—SLC22A2—Metabolism—GSTT1—urinary bladder cancer	3.91e-05	0.000522	CbGpPWpGaD
Reserpine—SLC22A1—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	3.86e-05	0.000515	CbGpPWpGaD
Reserpine—ABCB11—Metabolism—TYMS—urinary bladder cancer	3.85e-05	0.000514	CbGpPWpGaD
Reserpine—ABCB1—Metabolism—PRSS3—urinary bladder cancer	3.81e-05	0.000508	CbGpPWpGaD
Reserpine—ABCB11—Metabolism—NCOR1—urinary bladder cancer	3.81e-05	0.000508	CbGpPWpGaD
Reserpine—ABCB11—Metabolism—GSTM1—urinary bladder cancer	3.81e-05	0.000508	CbGpPWpGaD
Reserpine—SLC22A1—Metabolism—HPGDS—urinary bladder cancer	3.76e-05	0.000501	CbGpPWpGaD
Reserpine—SLC22A1—Metabolism—ENO2—urinary bladder cancer	3.76e-05	0.000501	CbGpPWpGaD
Reserpine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	3.73e-05	0.000497	CbGpPWpGaD
Reserpine—SLC22A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.66e-05	0.000488	CbGpPWpGaD
Reserpine—CYP3A5—Metabolism—NAT2—urinary bladder cancer	3.65e-05	0.000487	CbGpPWpGaD
Reserpine—ABCB11—Metabolism—GPX1—urinary bladder cancer	3.65e-05	0.000486	CbGpPWpGaD
Reserpine—SLC22A1—Metabolism—GSTT1—urinary bladder cancer	3.64e-05	0.000486	CbGpPWpGaD
Reserpine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	3.61e-05	0.000481	CbGpPWpGaD
Reserpine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	3.6e-05	0.00048	CbGpPWpGaD
Reserpine—ABCB11—Metabolism—ERCC2—urinary bladder cancer	3.58e-05	0.000478	CbGpPWpGaD
Reserpine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	3.43e-05	0.000458	CbGpPWpGaD
Reserpine—SLC22A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.41e-05	0.000455	CbGpPWpGaD
Reserpine—ABCB11—Metabolism—MTHFR—urinary bladder cancer	3.36e-05	0.000449	CbGpPWpGaD
Reserpine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	3.34e-05	0.000445	CbGpPWpGaD
Reserpine—SLC22A2—Metabolism—NQO1—urinary bladder cancer	3.25e-05	0.000434	CbGpPWpGaD
Reserpine—SLC22A2—Neuronal System—HRAS—urinary bladder cancer	3.17e-05	0.000423	CbGpPWpGaD
Reserpine—CYP3A5—Metabolism—RRM2—urinary bladder cancer	3.15e-05	0.000421	CbGpPWpGaD
Reserpine—ABCB1—Metabolism—TYMP—urinary bladder cancer	3.05e-05	0.000406	CbGpPWpGaD
Reserpine—SLC22A1—Metabolism—NQO1—urinary bladder cancer	3.03e-05	0.000404	CbGpPWpGaD
Reserpine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	2.99e-05	0.000399	CbGpPWpGaD
Reserpine—SLC22A1—Neuronal System—HRAS—urinary bladder cancer	2.96e-05	0.000395	CbGpPWpGaD
Reserpine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	2.92e-05	0.00039	CbGpPWpGaD
Reserpine—CYP3A5—Metabolism—ENO2—urinary bladder cancer	2.92e-05	0.000389	CbGpPWpGaD
Reserpine—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	2.92e-05	0.000389	CbGpPWpGaD
Reserpine—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	2.83e-05	0.000378	CbGpPWpGaD
Reserpine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	2.78e-05	0.000372	CbGpPWpGaD
Reserpine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	2.76e-05	0.000369	CbGpPWpGaD
Reserpine—ABCB1—Metabolism—NAT2—urinary bladder cancer	2.75e-05	0.000368	CbGpPWpGaD
Reserpine—ABCB11—Metabolism—PPARG—urinary bladder cancer	2.73e-05	0.000364	CbGpPWpGaD
Reserpine—SLC22A2—Metabolism—GSTP1—urinary bladder cancer	2.71e-05	0.000362	CbGpPWpGaD
Reserpine—ABCB11—Metabolism—CREBBP—urinary bladder cancer	2.62e-05	0.00035	CbGpPWpGaD
Reserpine—SLC22A1—Metabolism—GSTP1—urinary bladder cancer	2.53e-05	0.000337	CbGpPWpGaD
Reserpine—SLC22A2—Metabolism—TYMS—urinary bladder cancer	2.52e-05	0.000336	CbGpPWpGaD
Reserpine—SLC22A2—Metabolism—GSTM1—urinary bladder cancer	2.49e-05	0.000332	CbGpPWpGaD
Reserpine—SLC22A2—Metabolism—NCOR1—urinary bladder cancer	2.49e-05	0.000332	CbGpPWpGaD
Reserpine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	2.45e-05	0.000328	CbGpPWpGaD
Reserpine—SLC22A2—Metabolism—GPX1—urinary bladder cancer	2.38e-05	0.000318	CbGpPWpGaD
Reserpine—ABCB1—Metabolism—RRM2—urinary bladder cancer	2.38e-05	0.000317	CbGpPWpGaD
Reserpine—CYP3A5—Metabolism—NQO1—urinary bladder cancer	2.35e-05	0.000314	CbGpPWpGaD
Reserpine—SLC22A1—Metabolism—TYMS—urinary bladder cancer	2.35e-05	0.000313	CbGpPWpGaD
Reserpine—SLC22A2—Metabolism—ERCC2—urinary bladder cancer	2.34e-05	0.000312	CbGpPWpGaD
Reserpine—SLC22A1—Metabolism—GSTM1—urinary bladder cancer	2.32e-05	0.00031	CbGpPWpGaD
Reserpine—SLC22A1—Metabolism—NCOR1—urinary bladder cancer	2.32e-05	0.00031	CbGpPWpGaD
Reserpine—SLC22A1—Metabolism—GPX1—urinary bladder cancer	2.22e-05	0.000297	CbGpPWpGaD
Reserpine—ABCB1—Metabolism—ENO2—urinary bladder cancer	2.2e-05	0.000294	CbGpPWpGaD
Reserpine—ABCB1—Metabolism—HPGDS—urinary bladder cancer	2.2e-05	0.000294	CbGpPWpGaD
Reserpine—SLC22A2—Metabolism—MTHFR—urinary bladder cancer	2.2e-05	0.000294	CbGpPWpGaD
Reserpine—SLC22A1—Metabolism—ERCC2—urinary bladder cancer	2.18e-05	0.000291	CbGpPWpGaD
Reserpine—ABCB11—Metabolism—PTGS2—urinary bladder cancer	2.15e-05	0.000286	CbGpPWpGaD
Reserpine—ABCB1—Metabolism—GSTT1—urinary bladder cancer	2.14e-05	0.000285	CbGpPWpGaD
Reserpine—SLC22A1—Metabolism—MTHFR—urinary bladder cancer	2.05e-05	0.000274	CbGpPWpGaD
Reserpine—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2e-05	0.000267	CbGpPWpGaD
Reserpine—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	1.96e-05	0.000262	CbGpPWpGaD
Reserpine—ABCB11—Metabolism—PTEN—urinary bladder cancer	1.87e-05	0.00025	CbGpPWpGaD
Reserpine—CYP3A5—Metabolism—TYMS—urinary bladder cancer	1.82e-05	0.000243	CbGpPWpGaD
Reserpine—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	1.8e-05	0.000241	CbGpPWpGaD
Reserpine—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	1.8e-05	0.000241	CbGpPWpGaD
Reserpine—ABCB11—Metabolism—EP300—urinary bladder cancer	1.78e-05	0.000238	CbGpPWpGaD
Reserpine—SLC22A2—Metabolism—PPARG—urinary bladder cancer	1.78e-05	0.000238	CbGpPWpGaD
Reserpine—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.78e-05	0.000237	CbGpPWpGaD
Reserpine—CYP3A5—Metabolism—GPX1—urinary bladder cancer	1.73e-05	0.00023	CbGpPWpGaD
Reserpine—SLC22A2—Metabolism—CREBBP—urinary bladder cancer	1.71e-05	0.000229	CbGpPWpGaD
Reserpine—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	1.7e-05	0.000226	CbGpPWpGaD
Reserpine—SLC22A1—Metabolism—PPARG—urinary bladder cancer	1.66e-05	0.000222	CbGpPWpGaD
Reserpine—SLC22A1—Metabolism—CREBBP—urinary bladder cancer	1.6e-05	0.000213	CbGpPWpGaD
Reserpine—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	1.59e-05	0.000213	CbGpPWpGaD
Reserpine—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.48e-05	0.000198	CbGpPWpGaD
Reserpine—SLC22A2—Metabolism—PTGS2—urinary bladder cancer	1.4e-05	0.000187	CbGpPWpGaD
Reserpine—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.38e-05	0.000184	CbGpPWpGaD
Reserpine—ABCB1—Metabolism—GSTM1—urinary bladder cancer	1.36e-05	0.000182	CbGpPWpGaD
Reserpine—ABCB1—Metabolism—NCOR1—urinary bladder cancer	1.36e-05	0.000182	CbGpPWpGaD
Reserpine—SLC22A1—Metabolism—PTGS2—urinary bladder cancer	1.31e-05	0.000175	CbGpPWpGaD
Reserpine—ABCB1—Metabolism—GPX1—urinary bladder cancer	1.3e-05	0.000174	CbGpPWpGaD
Reserpine—CYP3A5—Metabolism—PPARG—urinary bladder cancer	1.29e-05	0.000172	CbGpPWpGaD
Reserpine—ABCB1—Metabolism—ERCC2—urinary bladder cancer	1.28e-05	0.000171	CbGpPWpGaD
Reserpine—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	1.24e-05	0.000166	CbGpPWpGaD
Reserpine—SLC22A2—Metabolism—PTEN—urinary bladder cancer	1.22e-05	0.000163	CbGpPWpGaD
Reserpine—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.2e-05	0.00016	CbGpPWpGaD
Reserpine—SLC22A2—Metabolism—EP300—urinary bladder cancer	1.17e-05	0.000156	CbGpPWpGaD
Reserpine—SLC22A1—Metabolism—PTEN—urinary bladder cancer	1.14e-05	0.000152	CbGpPWpGaD
Reserpine—SLC22A1—Metabolism—EP300—urinary bladder cancer	1.09e-05	0.000145	CbGpPWpGaD
Reserpine—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	1.02e-05	0.000136	CbGpPWpGaD
Reserpine—ABCB1—Metabolism—PPARG—urinary bladder cancer	9.75e-06	0.00013	CbGpPWpGaD
Reserpine—ABCB1—Metabolism—CREBBP—urinary bladder cancer	9.37e-06	0.000125	CbGpPWpGaD
Reserpine—CYP3A5—Metabolism—PTEN—urinary bladder cancer	8.86e-06	0.000118	CbGpPWpGaD
Reserpine—CYP3A5—Metabolism—EP300—urinary bladder cancer	8.45e-06	0.000113	CbGpPWpGaD
Reserpine—ABCB1—Metabolism—PTGS2—urinary bladder cancer	7.67e-06	0.000102	CbGpPWpGaD
Reserpine—ABCB1—Metabolism—PTEN—urinary bladder cancer	6.69e-06	8.93e-05	CbGpPWpGaD
Reserpine—ABCB1—Metabolism—EP300—urinary bladder cancer	6.38e-06	8.51e-05	CbGpPWpGaD
